Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial
Massachusetts General Hospital
160 participants
Aug 30, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
Eligibility
Inclusion Criteria3
- Age: > or equal to 18 years
- Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
- Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document
Exclusion Criteria2
- Non-English speaking (PROM surveys are only validated in English)
- Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bone marrow aspiration from the body of the ilium will be performed through one of the arthroscopic portals.
Standard of care hip arthroscopy without bone marrow aspiration will be performed in these patients.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06003101